Back to Journals » OncoTargets and Therapy » Volume 12

MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)

Total article views   HTML views PDF downloads Totals
17,099 Dovepress* 9,437+ 1,336 10,773
PubMed Central* 7,662 1,070 8,732
Totals 17,099 2,406 19,505
*Since 16 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar